We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-13.55%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$244B
AUM Growth
-$56.4B
Cap. Flow
-$9.23B
Cap. Flow %
-3.79%
Top 10 Hldgs %
13.08%
Holding
11,816
New
1,263
Increased
3,669
Reduced
5,058
Closed
1,051

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$641M
2
MSFT icon
Microsoft
MSFT
+$477M
3
ACN icon
Accenture
ACN
+$354M
4
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$332M
5
CVX icon
Chevron
CVX
+$304M

Sector Composition

Rank Sector Weight
1 Technology 11.68%
2 Healthcare 7.02%
3 Financials 6.95%
4 Consumer Discretionary 5.19%
5 Industrials 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CFIVW
9976
DELISTED
CF Acquisition Corp. IV Warrant
CFIVW
$1K ﹤0.01%
9,857
+2,144
+28% +$509
KORE.WS
9977
DELISTED
KORE Group Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
KORE.WS
$1K ﹤0.01%
1,677
SUAC.WS
9978
DELISTED
ShoulderUp Technology Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
SUAC.WS
$1K ﹤0.01%
4,498
-102
-2% -$21
CREXW
9979
DELISTED
Creative Realities, Inc. Warrant
CREXW
$1K ﹤0.01%
10,226
OPAD.WS
9980
DELISTED
Offerpad Solutions Inc. Warrants, Every 15 warrants will be exercisable for one share of Class A Common Stock at an exercise price of $172.50 per share of Class A Common Stock
OPAD.WS
$1K ﹤0.01%
4,698
+205
+5% +$127
CMRAW
9981
DELISTED
Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027
CMRAW
$1K ﹤0.01%
+4,900
New +$802
KBNTW
9982
DELISTED
Kubient, Inc. Warrant
KBNTW
$1K ﹤0.01%
5,137
-1,020
-17% -$311
ALOR
9983
DELISTED
ALSP Orchid Acquisition Corp I
ALOR
$1K ﹤0.01%
+105
New +$1.05K
CANO.WS
9984
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$1K ﹤0.01%
1,339
+47
+4% +$49
PRPC.WS
9985
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$1K ﹤0.01%
1,880
+1,719
+1,068% +$778
STLV
9986
DELISTED
iShares Factors US Value Style ETF
STLV
$1K ﹤0.01%
44
SKIL.WS
9987
DELISTED
Skillsoft Corp. Warrants, each whole warrant is exercisable for 1/20th of a share of Class A Common Stock at an exercise price of $230.00
SKIL.WS
$1K ﹤0.01%
1,210
+358
+42% +$313
ELYS
9988
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
$1K ﹤0.01%
1,994
-5,200
-72% -$7.01K
BIOSU
9989
DELISTED
BioPlus Acquisition Corp. Unit
BIOSU
$1K ﹤0.01%
91
-11
-11% -$110
UPTDU
9990
DELISTED
TradeUP Acquisition Corp. Unit
UPTDU
$1K ﹤0.01%
+140
New +$1.42K
FATH
9991
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$1K ﹤0.01%
+17
New +$1.94K
NRDY.WS
9992
DELISTED
Nerdy Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
NRDY.WS
$1K ﹤0.01%
3,854
-100
-3% -$58
OTMOW
9993
DELISTED
Otonomo Technologies Ltd. Warrant
OTMOW
$1K ﹤0.01%
8,419
-9,125
-52% -$1.2K
SNLN
9994
DELISTED
Highland/iBoxx Senior Loan ETF
SNLN
$1K ﹤0.01%
89
-597
-87% -$9.11K
KKR.PRC
9995
DELISTED
KKR & Co. Inc. 6.00% Series C Mandatory Convertible Preferred Stock
KKR.PRC
$1K ﹤0.01%
19
LFLY
9996
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
$1K ﹤0.01%
7
-9
-56% -$1.55K
HARP
9997
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$1K ﹤0.01%
64
-246
-79% -$6.37K
WAVC.U
9998
DELISTED
Waverley Capital Acquisition Corp. 1 Units, each consisting of one Class A Ordinary Share and one-third of one redeemable warrant
WAVC.U
$1K ﹤0.01%
+99
New +$966
CLVR
9999
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$1K ﹤0.01%
33
APGNW
10000
DELISTED
Apexigen, Inc. WarrantApexigen, Inc. Warrant
APGNW
$1K ﹤0.01%
8,453
+5,198
+160% +$861

Similar funds

UBS Group's Q2 2022 Portfolio in Review

As of Q2 2022, UBS Group held 11,816 positions worth $244B, down 19% from $300B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group withdrew a net $9.23B in Q2 2022, closing 1,051 positions and reducing 5,058 holdings. Its most notable exit was Cerner Corp, an estimated $177M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

Against the trend, UBS Group opened a new position in iShares 0-3 Month Treasury Bond ETF worth $13.8M.

  • UBS Group's largest Q2 2022 buy was iShares 0-3 Month Treasury Bond ETF: 137,765 shares worth $13.8M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $453M increase.
  • UBS Group's biggest Q2 2022 reduction was Apple, cutting an estimated $641M.
  • UBS Group fully exited Cerner Corp in Q2 2022, selling an estimated $177M.
  • UBS Group's ten largest holdings make up 13% of its $244B portfolio in Q2 2022.
  • UBS Group opened 1,263 new positions and closed 1,051 in Q2 2022.
  • UBS Group's portfolio value fell 19% quarter-over-quarter to $244B.

Based on UBS Group's 13F filing for Q2 2022, filed 10 Aug 2022.